Search

Your search keyword '"Bounameaux H"' showing total 1,106 results

Search Constraints

Start Over You searched for: Author "Bounameaux H" Remove constraint Author: "Bounameaux H"
1,106 results on '"Bounameaux H"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

8. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

12. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

13. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

14. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

15. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

16. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

17. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

18. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

19. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

20. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

21. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE

22. DVT Management and Outcome Trends, 2001 to 2014

23. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

24. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

25. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

27. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE

28. The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE

29. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE

30. Corrigendum to “Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE” (Thrombosis Research (2020) 191 (103–112), (S0049384820301523), (10.1016/j.thromres.2020.04.036))

31. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE

32. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease

33. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

37. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

38. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

40. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

42. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

43. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

44. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

45. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

47. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

49. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry

50. Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry

Catalog

Books, media, physical & digital resources